AMANDA PISCIOTTA: Open Payments
NPI 1558603811 · WATKINSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,104 in 58 payments from 16 companies in 2025. Trend: 2023 $1,297 · 2024 $1,101 · 2025 $1,104
Food & beverage: $1,094Education: $10
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $374 |
| ABBVIE INC. | 19 | $201 |
| UCB, Inc. | 9 | $180 |
| LEO Pharma Inc. | 3 | $78 |
| Incyte Corporation | 2 | $45 |
| PFIZER INC. | 2 | $37 |
| Galderma Laboratories, L.P. | 2 | $32 |
| Lilly USA, LLC | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Organon LLC | 1 | $20 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, RINVOQ, ADBRY, OPZELURA, CIBINQO, NEMLUVIO.
Industry payments across GA — which companies pay providers there.
